A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers

Clinical trial NCT02688374 · COMPLETED

Trial details

NCT number: NCT02688374
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tobacco Use Disorder

Start date: 2016-03-11
Primary completion: 2016-06-12
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.